Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$89.27 -1.63 (-1.79%)
At close: Oct 23, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Sale and Maturity of Investments (2016 - 2026)

Updated

Analysis

Rhythm Pharmaceuticals (RYTM) Sale and Maturity of Investments (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Rhythm Pharmaceuticals 6.14 Bn 5.01 Bn 62.32 Mn 57.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 57.50 Mn
Mar 31, 2026 99.25 Mn
Dec 31, 2025 51.65 Mn
Sep 30, 2025 61.50 Mn
Jun 30, 2025 80.99 Mn
Mar 31, 2025 58.33 Mn
Dec 31, 2024 87.54 Mn
Sep 30, 2024 45.31 Mn
Jun 30, 2024 57.75 Mn
Mar 31, 2024 70.05 Mn
Dec 31, 2023 63.29 Mn
Sep 30, 2023 74.50 Mn
Jun 30, 2023 124.50 Mn
Mar 31, 2023 92.68 Mn
Dec 31, 2022 59.64 Mn
Sep 30, 2022 61.48 Mn
Jun 30, 2022 51.00 Mn
Mar 31, 2022 112.13 Mn
Dec 31, 2021 69.05 Mn
Sep 30, 2021 156.66 Mn
API Access

Rhythm Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=RYTM&period=max&api_key=YOUR_API_KEY